UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The intriguing relationship between coronary heart disease and mental disorders

Dialogues in clinical neuroscience, 2018-03, Vol.20 (1), p.31-40

2018

Volltextzugriff (PDF)

Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness

Frontiers in endocrinology (Lausanne), 2020-10, Vol.11, p.573479-573479

2020

Volltextzugriff (PDF)

COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review

Frontiers in psychiatry, 2022-01, Vol.12, p.798554-798554

2022

Volltextzugriff (PDF)

Depression and post-traumatic stress disorder after perinatal loss in fathers: A systematic review

European psychiatry, 2022-01, Vol.65 (1), p.e72-e72, Article e72

2022

Volltextzugriff (PDF)

COVID-19 Vaccination Rates in a Cohort Study of Patients With Mental Illness in Residential and Community Care

Frontiers in psychiatry, 2021-12, Vol.12, p.805528

2021

Volltextzugriff (PDF)

Barriers to Somatic Health Care for Persons With Severe Mental Illness in Belgium: A Qualitative Study of Patients' and Healthcare Professionals' Perspectives

Frontiers in psychiatry, 2022-01, Vol.12, p.798530-798530

2022

Volltextzugriff (PDF)

Media coverage of Belgium's first criminal case concerning euthanasia for psychiatric patients: A content analysis of Flemish newspapers and magazines

Frontiers in psychiatry, 2023-01, Vol.13, p.1050086-1050086

2023

Volltextzugriff (PDF)

COVID-19 vaccination for people with severe mental illness: why, what, and how?

The Lancet. Psychiatry, 2021-05, Vol.8 (5), p.444-450

2021

Volltextzugriff (PDF)

Diabetes, physical activity participation and exercise capacity in patients with schizophrenia

Psychiatry and clinical neurosciences, 2013-09, Vol.67 (6), p.451-456

2013

Volltextzugriff (PDF)

The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication

JAMA psychiatry (Chicago, Ill.), 2018-08, Vol.75 (8), p.771

2018

Volltextzugriff (PDF)

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

World psychiatry, 2015-06, Vol.14 (2), p.119-136

2015

Volltextzugriff (PDF)

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

Nature reviews. Endocrinology, 2012-02, Vol.8 (2), p.114-126

2012

Volltextzugriff (PDF)

Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review

Expert opinion on drug safety, 2016-06, Vol.15 (6), p.809-823

2016

Volltextzugriff (PDF)

Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review

CNS drugs, 2024-02, Vol.38 (2), p.105-123

2024

Volltextzugriff (PDF)

Evaluating Monitoring Guidelines of Clozapine‑Induced Adverse Effects: a Systematic Review

CNS drugs, 2024-02, Vol.38 (2), p.105-123

2024

Volltextzugriff (PDF)

Prioritizing COVID‐19 vaccination for people with severe mental illness

World psychiatry, 2021-02, Vol.20 (1), p.54-55

2021

Volltextzugriff (PDF)

Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis

CNS drugs, 2019-06, Vol.33 (6), p.549-566

2019

Volltextzugriff (PDF)

Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review

Journal of the American College of Cardiology, 2022-08, Vol.80 (9), p.918-933

2022

Volltextzugriff (PDF)

Reversing the downward spiral for people with severe mental illness through educational innovations

World psychiatry, 2017-02, Vol.16 (1), p.41-42

2017

Volltextzugriff (PDF)

The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity: A Scoping Review

ALPHA PSYCHIATRY, 2024-03, Vol.25 (2), p.190-205

2024

Volltextzugriff (PDF)

Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta‐analysis

Acta psychiatrica Scandinavica, 2021-04, Vol.143 (4), p.294-306

2021

Volltextzugriff (PDF)

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

CNS drugs, 2012-09, Vol.26 (9), p.733

2012

Volltextzugriff (PDF)

The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics

CNS drugs, 2015-08, Vol.29 (8), p.637-658

2015

Volltextzugriff (PDF)

Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review

Expert opinion on drug safety, 2014-05, Vol.13 (5), p.605-624

2014

Volltextzugriff (PDF)

Severe Mental Illness and Cardiovascular Disease

Journal of the American College of Cardiology, 2022-08, Vol.80 (9), p.918-933

2022

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(30)
Science & Technology
(30)
Psychiatry
(24)
Humans
(13)
Schizophrenia
(13)
Systematic Review
(9)
Antipsychotic Agents - Therapeutic Use
(8)
Antipsychotics
(8)
Mental Disorders
(7)
Antipsychotic Agents - Adverse Effects
(6)
Bipolar Disorder
(6)
Neurosciences
(6)
Neurosciences & Neurology
(6)
Pharmacology & Pharmacy
(6)
Severe Mental Illness
(6)
Clinical Neurology
(5)
Psychotropic Drugs
(5)
Schizophrenia - Drug Therapy
(5)
Adult
(4)
Depression
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The intriguing relationship between coronary heart disease and mental disorders

Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness

COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review

Depression and post-traumatic stress disorder after perinatal loss in fathers: A systematic review

COVID-19 Vaccination Rates in a Cohort Study of Patients With Mental Illness in Residential and Community Care

Barriers to Somatic Health Care for Persons With Severe Mental Illness in Belgium: A Qualitative Study of Patients' and Healthcare Professionals' Perspectives

Media coverage of Belgium's first criminal case concerning euthanasia for psychiatric patients: A content analysis of Flemish newspapers and magazines

COVID-19 vaccination for people with severe mental illness: why, what, and how?

Diabetes, physical activity participation and exercise capacity in patients with schizophrenia

The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review

Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review

Evaluating Monitoring Guidelines of Clozapine‑Induced Adverse Effects: a Systematic Review

Prioritizing COVID‐19 vaccination for people with severe mental illness

Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis

Severe Mental Illness and Cardiovascular Disease: JACC State-of-the-Art Review

Reversing the downward spiral for people with severe mental illness through educational innovations

The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity: A Scoping Review

Does lithium prevent relapse following successful electroconvulsive therapy for major depression? A systematic review and meta‐analysis

Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder

The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics

Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review

Severe Mental Illness and Cardiovascular Disease

Suchergebnisse filtern